rs147493705

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 3P and 9B. PM1PP2BP4_StrongBP6BS2

The NM_000083.3(CLCN1):​c.1480T>C​(p.Phe494Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000242 in 1,612,644 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. F494F) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

CLCN1
NM_000083.3 missense

Scores

2
10
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 8.01

Publications

1 publications found
Variant links:
Genes affected
CLCN1 (HGNC:2019): (chloride voltage-gated channel 1) The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence homology. The protein encoded by this gene regulates the electric excitability of the skeletal muscle membrane. Mutations in this gene cause two forms of inherited human muscle disorders: recessive generalized myotonia congenita (Becker) and dominant myotonia (Thomsen). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
CLCN1 Gene-Disease associations (from GenCC):
  • myotonia congenita, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • myotonia congenita, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Thomsen and Becker disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 6 uncertain in NM_000083.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 106 curated pathogenic missense variants (we use a threshold of 10). The gene has 18 curated benign missense variants. Gene score misZ: 0.21191 (below the threshold of 3.09). Trascript score misZ: 0.95247 (below the threshold of 3.09). GenCC associations: The gene is linked to myotonia congenita, autosomal dominant, myotonia congenita, autosomal recessive, Thomsen and Becker disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.044286817).
BP6
Variant 7-143339519-T-C is Benign according to our data. Variant chr7-143339519-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 418134.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCN1NM_000083.3 linkc.1480T>C p.Phe494Leu missense_variant Exon 14 of 23 ENST00000343257.7 NP_000074.3
CLCN1NR_046453.2 linkn.1435T>C non_coding_transcript_exon_variant Exon 13 of 22

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCN1ENST00000343257.7 linkc.1480T>C p.Phe494Leu missense_variant Exon 14 of 23 1 NM_000083.3 ENSP00000339867.2
CLCN1ENST00000432192.6 linkn.*765T>C non_coding_transcript_exon_variant Exon 14 of 23 1 ENSP00000395949.2
CLCN1ENST00000432192.6 linkn.*765T>C 3_prime_UTR_variant Exon 14 of 23 1 ENSP00000395949.2
CLCN1ENST00000650516.2 linkc.1480T>C p.Phe494Leu missense_variant Exon 14 of 23 ENSP00000498052.2

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
185
AN:
152170
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00417
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000590
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000342
AC:
86
AN:
251454
AF XY:
0.000287
show subpopulations
Gnomad AFR exome
AF:
0.00406
Gnomad AMR exome
AF:
0.000549
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000136
AC:
198
AN:
1460356
Hom.:
0
Cov.:
31
AF XY:
0.000113
AC XY:
82
AN XY:
726588
show subpopulations
African (AFR)
AF:
0.00457
AC:
153
AN:
33446
American (AMR)
AF:
0.000470
AC:
21
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5760
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110622
Other (OTH)
AF:
0.000365
AC:
22
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00126
AC:
192
AN:
152288
Hom.:
2
Cov.:
32
AF XY:
0.00133
AC XY:
99
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00433
AC:
180
AN:
41572
American (AMR)
AF:
0.000589
AC:
9
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000501
Hom.:
0
Bravo
AF:
0.00141
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000354
AC:
43
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Mar 20, 2018
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the CLCN1 gene. The F494L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The F494L variant is observed in 37/10402 (0.4%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The F494L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Additionally, a missense variant at the same residue (F494S) and in nearby residues (A493E/V, R496S, G499R) have been reported in the Human Gene Mutation Database in association with CLCN1-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

not specified Benign:1
Nov 01, 2023
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myotonia, autosomal recessive form;C2936781:Congenital myotonia, autosomal dominant form Benign:1
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.77
D
Eigen
Benign
0.061
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.044
T
MetaSVM
Uncertain
-0.0019
T
MutationAssessor
Benign
1.5
L
PhyloP100
8.0
PrimateAI
Pathogenic
0.85
D
PROVEAN
Uncertain
-4.3
D
REVEL
Uncertain
0.49
Sift
Benign
0.13
T
Sift4G
Benign
0.10
T
Polyphen
0.052
B
Vest4
0.93
MutPred
0.49
Loss of catalytic residue at F494 (P = 0.0269);
MVP
0.94
MPC
0.40
ClinPred
0.10
T
GERP RS
5.1
Varity_R
0.71
gMVP
0.86
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147493705; hg19: chr7-143036612; API